Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinicoeconomics and Outcomes Research : CEOR|February 21, 2012
Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular eventsSanjay K Gandhi, Marie M Jensen, Kathleen M Fox, et al.
Advances in Therapy|June 7, 2013
Tumor necrosis factor-blocker dose escalation in rheumatoid arthritis patients in a pharmacy benefit management settingSteven W Blume, Kathleen M Fox, George Joseph, et al.
Journal of the American Academy of Dermatology|April 2, 2008
Psoriasis treatment patterns: results of a cross-sectional survey of dermatologistsVaishali Patel, Elizabeth J Horn, Steve J Lobosco, et al.
Neurourology and Urodynamics|November 26, 2008
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q)Mary Kay Margolis, Kathleen M Fox, Annamaria Cerulli, et al.
Rheumatology and Therapy|September 6, 2021
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid ArthritisElizabeth A Holdsworth, Bethany Donaghy, Kathleen M Fox, et al.
Rheumatology and Therapy|July 14, 2022
The Economic Benefit of Remission for Patients with Rheumatoid ArthritisJeffrey R Curtis, Kathleen M Fox, Fenglong Xie, et al.
BMC Public Health|August 16, 2019
Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based studyHyungtae Kim, Siin Kim, Sola Han, et al.
BMJ Open Diabetes Research & Care|October 6, 2015
Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease riskRuben G W Quek, Kathleen M Fox, Li Wang, et al.
BMC Nephrology|January 26, 2012
Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational studyKathleen M Fox, Jerry Yee, Ze Cong, et al.
The American Journal of Cardiology|January 9, 2016
A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary EventRuben G W Quek, Kathleen M Fox, Li Wang, et al.
Pageof 10